Rapamycin formulation encapsulated in reconstituted high-density lipoprotein containing V156K-apoA-I
展开▼
机译:雷帕霉素制剂包封在含有V156K-apoA-I的重组高密度脂蛋白中
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided is a rapamycin formulation using a recombinant high-density lipoprotein including apolipoprotein mutant, the rapamycin formulation in which solubility of rapamycin and medical use, such as aging suppression and arteriosclerosis suppression, are improved by using recombinant high-density lipoprotein including apolipoprotein A-I and its mutant V156K.
展开▼